top of page
Browse by category
Search


Some plastic surgeons are treating obesity as a cosmetic issue rather than a chronic disease
Researchers from the College of Public Health, Temple University, Philadelphia, PA, have warned how some plastic surgeons are promoting...


AOMs associated with weight recurrence post-treatment
Patients prescribed drugs to help them lose weight may experience a recurrence in weight gain after stopping their anti-obesity...


Anti-obesity medications can raise testosterone levels in men
Anti-obesity medications can significantly raise testosterone levels and improve health outcomes for men with obesity or type 2 diabetes,...


BOMSS changes name to include all obesity specialists
Bariatric News spoke with Professor Ahmed Ahmed (Associate Professor in Metabolic Surgery and Lead Bariatric Surgeon at Imperial College...


Expanding access to anti-obesity medications delivers 13% return on investment for society
A USC Schaeffer Center white paper entitled, ‘Lifetime Social Returns From Expanding Access to Anti-Obesity Medication’, finds expanded...


Medicare and other insurance should cover obesity drugs
A large majority of older Americans feel that health insurance - including Medicare - should cover anti-obesity medications, according to...


Journal Watch 19/06/2024
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...


MBS more effective and durable than new AOMs and lifestyle intervention
Systematic reviews of medical literature between 2020 and 2024 show that bariatric and metabolic surgery produces the greatest and most...


Experts issue nutritional recommendations for patients treated with anti-obesity medications
Individuals treated with anti-obesity medications generally experience reduced appetite, which typically leads to reduced food intake. As...


Journal Watch 8/5/2024
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Browse by tag






bottom of page